Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Inventory (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Inventory for 4 consecutive years, with $83.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Inventory fell 22.68% year-over-year to $83.3 million, compared with a TTM value of $83.3 million through Dec 2024, down 22.68%, and an annual FY2024 reading of $83.3 million, down 22.68% over the prior year.
  • Inventory was $83.3 million for Q4 2024 at Cresco Labs, down from $107.8 million in the prior quarter.
  • Across five years, Inventory topped out at $136.6 million in Q4 2021 and bottomed at $67.2 million in Q4 2020.
  • Average Inventory over 4 years is $98.7 million, with a median of $95.6 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 103.39% in 2021, then fell 22.68% in 2024.
  • Year by year, Inventory stood at $67.2 million in 2020, then skyrocketed by 103.39% to $136.6 million in 2021, then decreased by 21.12% to $107.8 million in 2023, then dropped by 22.68% to $83.3 million in 2024.
  • Business Quant data shows Inventory for CRLBF at $83.3 million in Q4 2024, $107.8 million in Q4 2023, and $136.6 million in Q4 2021.